Browse
Submit Data
Databases
API
Help

Dataset Information

9 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of CD47 Blockade on Vascular Inflammation.

ABSTRACT:

SUBMITTER: Jarr KU

PROVIDER: S-EPMC8175009 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

Blockade of NOX2 and STIM1 signaling limits lipopolysaccharide-induced vascular inflammation.

Project description: Not available

| S-EPMC3561818 | biostudies-other

Blockade of CD47 enhances the antitumor effect of macrophages in renal cell carcinoma through trogocytosis.

Project description: Not available

| S-EPMC9307775 | biostudies-literature

Synergistic effect of CD47 blockade in combination with cordycepin treatment against cancer

Project description:Cordycepin was widely considered as a direct tumor-suppressive drug, however, and as of now few studies have been presented to investigate the effect of cordycepin therapy to the tumor microenvironment (TME). In our study, we demonstrated that cordycepin would decrease the function of M1-like macrophage in TME, and also contribute to macrophage polarization (M2-macrophage). Herein, we tried to establish a combined therapeutic strategy of cordycepin and anti-CD47 antibody. Using single cell RNA sequencing, we improved that the combined treatment would significantly increase the effect of cordycepin, which would reactivate macrophages and reverse macrophage polarization. And then, the combined treatment would regulate the proportion of CD8+T cells to increase the PFS for digestive tract malignancy patients. Finally, Flow cytometry was used to validate the change of percentage for TAM and TIL. Our finding suggests the combined treatment of cordycepin and anti-CD47 mAb could significantly increase tumor suppression, which could increase M1-macrophage and decrease M2-macrophage. The PFS for digestive tract malignancy patients would be increased though regulation of CD8+T cells.

2023-03-30 | GSE224945 | GEO

Blockade of vascular endothelial growth factor receptor 1 prevents inflammation and vascular leakage in diabetic retinopathy.

Project description: Not available

| S-EPMC4363713 | biostudies-literature

CD47 Deficiency Ameliorates Ocular Autoimmune Inflammation.

Project description: Not available

| S-EPMC8174453 | biostudies-literature

Blockade of the kallikrein-kinin system reduces endothelial complement activation in vascular inflammation.

Project description: Not available

| S-EPMC6796560 | biostudies-literature

CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer.

Project description: Not available